1. Home
  2. PCRX vs TYG Comparison

PCRX vs TYG Comparison

Compare PCRX & TYG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.25

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Tortoise Energy Infrastructure Corporation

TYG

Tortoise Energy Infrastructure Corporation

HOLD

Current Price

$46.02

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
TYG
Founded
2006
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2010
2003

Fundamental Metrics

Financial Performance
Metric
PCRX
TYG
Price
$23.25
$46.02
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$30.25
N/A
AVG Volume (30 Days)
516.5K
150.3K
Earning Date
04-30-2026
05-04-2026
Dividend Yield
N/A
11.71%
EPS Growth
107.44
N/A
EPS
0.07
N/A
Revenue
$541,533,000.00
N/A
Revenue This Year
$6.78
N/A
Revenue Next Year
$8.54
N/A
P/E Ratio
$336.29
$52.62
Revenue Growth
26.04
N/A
52 Week Low
$18.80
$40.01
52 Week High
$27.64
$51.18

Technical Indicators

Market Signals
Indicator
PCRX
TYG
Relative Strength Index (RSI) 49.85 40.23
Support Level $22.13 $45.32
Resistance Level $24.20 $50.87
Average True Range (ATR) 1.02 0.92
MACD -0.06 -0.14
Stochastic Oscillator 42.93 19.92

Price Performance

Historical Comparison
PCRX
TYG

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About TYG Tortoise Energy Infrastructure Corporation

Tortoise Energy Infrastructure Corp seeks to provide a high level of current income to stockholders. It invests in fixed-income and dividend-paying equity securities of power and energy infrastructure companies that provide stable and defensive characteristics throughout economic cycles.

Share on Social Networks: